MXPA00006438A - Tts que contiene un antioxidante. - Google Patents

Tts que contiene un antioxidante.

Info

Publication number: MXPA00006438A
Authority: MX; Mexico
Prior art keywords: antioxidant; ethyl; tts containing; tts; carbamate
Prior art date: 1998-01-12

Application number

MXPA00006438A

Other languages

English (en)

Inventor

Bodo Asmussen

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-12

Filing date

1999-01-08

Publication date

2003-07-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10825116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA00006438(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-01-08 Application filed by Novartis Ag filed Critical Novartis Ag

2003-07-21 Publication of MXPA00006438A publication Critical patent/MXPA00006438A/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Hospice & Palliative Care (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Anti-Oxidant Or Stabilizer Compositions (AREA)
Fats And Perfumes (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Dental Preparations (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Compositions Of Macromolecular Compounds (AREA)

MXPA00006438A 1998-01-12 1999-01-08 Tts que contiene un antioxidante. MXPA00006438A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9800526.7A GB9800526D0 (en)	1998-01-12	1998-01-12	Organic compounds
PCT/EP1999/000078 WO1999034782A1 (en)	1998-01-12	1999-01-08	Tts containing an antioxidant

Publications (1)

Publication Number	Publication Date
MXPA00006438A true MXPA00006438A (es)	2003-07-21

Family

ID=10825116

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA00006438A MXPA00006438A (es)	1998-01-12	1999-01-08	Tts que contiene un antioxidante.

Country Status (25)

Country	Link
US (1)	US6335031B1 (es)
EP (1)	EP1047409B1 (es)
KR (1)	KR100569051B1 (es)
CN (1)	CN1129427C (es)
AT (1)	ATE223711T1 (es)
AU (1)	AU745661B2 (es)
BR (1)	BR9906920A (es)
CA (1)	CA2315784C (es)
CZ (1)	CZ300598B6 (es)
DE (1)	DE69902875T2 (es)
DK (1)	DK1047409T3 (es)
ES (1)	ES2184408T3 (es)
GB (1)	GB9800526D0 (es)
HU (1)	HU227159B1 (es)
ID (1)	ID27503A (es)
IL (1)	IL137100A (es)
MX (1)	MXPA00006438A (es)
NO (1)	NO328390B1 (es)
NZ (1)	NZ505650A (es)
PL (1)	PL201328B1 (es)
PT (1)	PT1047409E (es)
RU (1)	RU2219926C2 (es)
SK (1)	SK284622B6 (es)
TR (2)	TR200001688T2 (es)
WO (1)	WO1999034782A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100603900B1 (ko)	1998-10-01	2006-07-25	노파르티스 아게	신규의 서방성 경구 제제
FR2793689B1 (fr) *	1999-05-19	2001-08-24	Pf Medicament	Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
AU779523B2 (en) *	1999-11-29	2005-01-27	Lts Lohmann Therapie-Systeme Ag	Transdermal therapeutic systems with improved stability and a method for the production thereof
DE10107663B4 (de) *	2001-02-19	2004-09-09	Lts Lohmann Therapie-Systeme Ag	Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
ITMI20020798A1 (it) *	2002-04-15	2003-10-15	F T Holding S A	Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
FR2881653A1 (fr) *	2005-02-04	2006-08-11	Frederic Khodja	Dispositif permettant l'administration en continu d'une dose physiologique controlee d'au moins un mineral ou une vitamine
TWI389709B (zh) *	2005-12-01	2013-03-21	Novartis Ag	經皮治療系統
WO2009022345A1 (en) *	2007-08-14	2009-02-19	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Phenyl carbamates for the treatment of multiple sclerosis
GEP20146166B (en)	2008-07-28	2014-09-25	Takeda Pharmaceuticals Co	Pharmaceutical composition
US20100087768A1 (en) *	2008-10-02	2010-04-08	Forlano Paula	Transdermal drug delivery system for liquid active ingredient
US10076502B2 (en)	2009-12-22	2018-09-18	Luye Pharma Ag	Transdermal therapeutic system for administering rivastigmine or derivatives thereof
MX350357B (es)	2009-12-22	2017-09-05	Luye Pharma Ag	Sistema terapeutico transdermico para administrar rivastigmina o derivados de este.
ES2363395B1 (es) *	2010-01-20	2012-02-23	Farmalider, S.A.	Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral.
WO2011151359A1 (en)	2010-06-02	2011-12-08	Noscira, S.A.	Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
DE102010026903A1 (de)	2010-07-12	2012-01-12	Amw Gmbh	Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
CN103068944B (zh)	2010-07-21	2016-03-09	3M创新有限公司	透皮粘合剂组合物、装置及方法
EP2468274B1 (de) *	2010-12-14	2015-07-01	Acino AG	Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs
KR101788802B1 (ko) *	2010-12-24	2017-10-20	주식회사 삼양바이오팜	리바스티그민을 함유하는 경피흡수제제
KR20120126898A (ko) *	2011-05-13	2012-11-21	에스케이케미칼주식회사	리바스티그민 또는 이의 염을 함유하는 경피 투여 조성물
KR20120130073A (ko) *	2011-05-20	2012-11-28	에스케이케미칼주식회사	리바스티그민 함유 패취
EP2711002A4 (en)	2011-05-20	2014-10-29	Sk Chemicals Co Ltd	PLASTER WITH RIVASTIGMIN
EP2594261A1 (en)	2011-11-18	2013-05-22	Labtec GmbH	Composition for transdermal administration of rivastigmine
DE102012000369A1 (de)	2012-01-11	2013-07-11	Alfred E. Tiefenbacher (Gmbh & Co. Kg)	Transdermales therapeutisches System mit Cholinesterase-Hemmer
WO2013142339A1 (en)	2012-03-23	2013-09-26	Novartis Ag	Transdermal therapeutic system and method
JP6153135B2 (ja)	2012-06-12	2017-06-28	株式会社ケイ・エムトランスダーム	貼付剤
CN104602687A (zh) *	2012-09-03	2015-05-06	尼普洛外用药品株式会社	贴剂
KR20140038237A (ko)	2012-09-20	2014-03-28	에스케이케미칼주식회사	리바스티그민의 안정성이 개선된 의약품
WO2014051128A1 (ja)	2012-09-28	2014-04-03	株式会社ケイ・エムトランスダーム	貼付剤
WO2014111790A2 (en)	2013-01-15	2014-07-24	Zydus Technologies Limited	Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
US9949935B2 (en) *	2014-04-08	2018-04-24	Teikoku Pharma Usa, Inc.	Rivastigmine transdermal compositions and methods of using the same
JPWO2015174502A1 (ja)	2014-05-15	2017-05-25	ニチバン株式会社	リバスチグミンを含有する貼付剤のための包装体
KR102710072B1 (ko)	2018-08-31	2024-09-24	에스케이케미칼 주식회사	장기 투여용 리바스티그민 패취
KR102823139B1 (ko)	2018-08-31	2025-06-19	에스케이케미칼 주식회사	장기 투여용 리바스티그민 패취
CN115087445A (zh) *	2020-02-19	2022-09-20	住友制药株式会社	经皮吸收制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU201906B (en) *	1987-03-04	1991-01-28	Sandoz Ag	Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
GB9213322D0 (en) *	1992-06-23	1992-08-05	Efamol Holdings	Antioxidant compositions
AU5716898A (en) *	1997-01-08	1998-08-03	Warner-Lambert Company	Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
EP0952826B1 (en) *	1997-01-17	2001-11-14	Takeda Chemical Industries, Ltd.	Idebenone containing combination agent for treating alzheimer's disease

1998
- 1998-01-12 GB GBGB9800526.7A patent/GB9800526D0/en not_active Ceased
1999
- 1999-01-08 TR TR2000/01688T patent/TR200001688T2/xx unknown
- 1999-01-08 NZ NZ505650A patent/NZ505650A/xx not_active IP Right Cessation
- 1999-01-08 RU RU2000120951/15A patent/RU2219926C2/ru active
- 1999-01-08 PT PT99902525T patent/PT1047409E/pt unknown
- 1999-01-08 CZ CZ20002557A patent/CZ300598B6/cs not_active IP Right Cessation
- 1999-01-08 TR TR2001/01021T patent/TR200101021T2/xx unknown
- 1999-01-08 PL PL341347A patent/PL201328B1/pl unknown
- 1999-01-08 MX MXPA00006438A patent/MXPA00006438A/es active IP Right Grant
- 1999-01-08 AU AU22785/99A patent/AU745661B2/en not_active Expired
- 1999-01-08 WO PCT/EP1999/000078 patent/WO1999034782A1/en not_active Ceased
- 1999-01-08 CN CN99802092A patent/CN1129427C/zh not_active Expired - Lifetime
- 1999-01-08 BR BR9906920-2A patent/BR9906920A/pt not_active Application Discontinuation
- 1999-01-08 DE DE69902875T patent/DE69902875T2/de not_active Expired - Lifetime
- 1999-01-08 DK DK99902525T patent/DK1047409T3/da active
- 1999-01-08 ID IDW20001301A patent/ID27503A/id unknown
- 1999-01-08 SK SK1053-2000A patent/SK284622B6/sk not_active IP Right Cessation
- 1999-01-08 CA CA002315784A patent/CA2315784C/en not_active Expired - Lifetime
- 1999-01-08 ES ES99902525T patent/ES2184408T3/es not_active Expired - Lifetime
- 1999-01-08 HU HU0004300A patent/HU227159B1/hu unknown
- 1999-01-08 KR KR1020007006433A patent/KR100569051B1/ko not_active Ceased
- 1999-01-08 IL IL13710099A patent/IL137100A/en not_active IP Right Cessation
- 1999-01-08 EP EP99902525A patent/EP1047409B1/en not_active Expired - Lifetime
- 1999-01-08 AT AT99902525T patent/ATE223711T1/de active
- 1999-04-14 US US09/291,498 patent/US6335031B1/en not_active Expired - Lifetime
2000
- 2000-07-05 NO NO20003472A patent/NO328390B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
NO328390B1 (no)	2010-02-08
SK10532000A3 (sk)	2000-11-07
DE69902875D1 (de)	2002-10-17
NZ505650A (en)	2002-10-25
CN1288375A (zh)	2001-03-21
HUP0004300A3 (en)	2003-05-28
ID27503A (id)	2001-04-12
DE69902875T2 (de)	2003-05-22
BR9906920A (pt)	2000-10-10
CA2315784C (en)	2006-06-27
PT1047409E (pt)	2002-12-31
CZ300598B6 (cs)	2009-06-24
ES2184408T3 (es)	2003-04-01
DK1047409T3 (da)	2002-12-30
NO20003472D0 (no)	2000-07-05
JP2002500178A (ja)	2002-01-08
WO1999034782A1 (en)	1999-07-15
PL201328B1 (pl)	2009-03-31
CA2315784A1 (en)	1999-07-15
CN1129427C (zh)	2003-12-03
HK1034036A1 (en)	2001-10-12
JP3820103B2 (ja)	2006-09-13
AU2278599A (en)	1999-07-26
CZ20002557A3 (cs)	2000-10-11
EP1047409B1 (en)	2002-09-11
PL341347A1 (en)	2001-04-09
SK284622B6 (sk)	2005-08-04
US6335031B1 (en)	2002-01-01
AU745661B2 (en)	2002-03-28
KR20010033072A (ko)	2001-04-25
NO20003472L (no)	2000-08-07
KR100569051B1 (ko)	2006-04-10
IL137100A (en)	2004-12-15
HUP0004300A2 (hu)	2001-05-28
TR200101021T2 (tr)	2002-06-21
IL137100A0 (en)	2001-06-14
RU2219926C2 (ru)	2003-12-27
HU227159B1 (en)	2010-09-28
GB9800526D0 (en)	1998-03-11
EP1047409A1 (en)	2000-11-02
TR200001688T2 (tr)	2000-11-21
ATE223711T1 (de)	2002-09-15

Publication	Publication Date	Title
IL137100A0 (en)	2001-06-14	Tts containing an antioxidant
BG66093B1 (bg)	2011-04-29	Състави с контролирано освобождаване, съдържащи нимесулид
MX9602656A (es)	1998-06-30	Dispositivo transdermico que contiene pirrolidona polivinilica como mejorador de solubilidad.
BR0008590A (pt)	2001-10-30	Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
TW355683B (en)	1999-04-11	Composition containing micronized nebivolol
MX9705954A (es)	1998-02-28	Formulaciones y metodos para reducir irritacion de la piel.
AU2003274681A8 (en)	2004-02-23	Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
MXPA01007411A (es)	2003-06-06	Composiciones y metodos para suministro mucoso.
UA42061C2 (uk)	2001-10-15	Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
SE9301171D0 (sv)	1993-04-07	Pharmaceutical composition containing lipophilic drugs
ATE324907T1 (de)	2006-06-15	Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
GR3035831T3 (en)	2001-08-31	Veterinary composition containing a proton pump inhibitor
ATE288256T1 (de)	2005-02-15	Dermale zusammensetzungen
BG101446A (bg)	1998-04-30	Антинеопластични какаови екстракти, метод за получаване и използване
AU4451101A (en)	2001-10-30	Method and compositions for preventing hormone induced adverse effects
IL179718A0 (en)	2007-05-15	Pharmaceutical composition containing irbesartan
NZ511085A (en)	2002-10-25	Oral pharmaceutical compositions containing buprenorphin
HUP0100539A2 (hu)	2001-08-28	D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
CA2251966A1 (en)	1997-10-30	Transdermally administered dextromethorphan as antitussive agent
HRP20010684B1 (hr)	2011-01-31	Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina
DK1303278T3 (da)	2009-02-09	Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
BG105570A (en)	2002-02-28	Pharmaceutical compositions for modified release insulin sensitiser
TR200400241T4 (tr)	2004-04-21	Lasofoksifen'in transdermal olarak verilmesi
CA2380128A1 (en)	2001-12-06	Plasters containing 4-biphenylacetic acid
PL348202A1 (en)	2002-05-06	Pharmaceutically active composition and dispensing device

Legal Events

Date	Code	Title	Description
2005-09-07	FG	Grant or registration
2014-01-13	GD	Licence granted